Dermatology Xagena
FDA is investigating postmarketing reports of lymphoma and skin cancer in children and adults treated with Elidel ( Pimecrolimus ), but the causal relationship has not been clearly established. FDA ...
The FDA ( Food and Drug Administration ) advised health care professionals to prescribe Elidel ( Pimecrolimus ) and Protopic ( Tacrolimus ) only as directed and only after other atopic dermatitis ( ec ...
Bacterial resistance to conventional antibiotics has become increasingly common, resulting in escalating life-threatening infections. In an effort to find an alternative treatment for antibiotic-re ...
A Mayo Clinic study has revealed the most common causes of allergic contact dermatitis, a skin inflammation resulting in swollen, reddened and itchy skin due to direct contact with an allergen. To ...
Results from a phase 2b dose-ranging study of Dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis, a serious, chronic form of eczema were presented. All ...
Keytruda ( Pembrolizumab ) is indicated in the United States at a dose of 2 mg/kg administered as an intravenous infusion over 30 minutes every three weeks for the treatment of patients with ...
The results from the one-year phase 3 CHRONOS study have shown that patients receiving the investigational drug Dupilumab ( Dupixent ) with topical corticosteroids ( TCS ) achieved significantly impro ...
Bristol-Myers Squibb pioneered the use of immune checkpoint inhibitors for the adjuvant treatment of melanoma, beginning with Yervoy. Five-year overall survival data from the phase 3 CA184-029 trial ...
In the U.S.A., an Investigator's Global Assessment ( IGA ) score of less than or equal to 1 ( clear or almost clear skin ) has been the standard measure in regulatory outcomes for registration clinica ...
Dupilumab ( Dupixent ) is the first biologic available to treat atopic dermatitis. Its effectiveness and safety were demonstrated in clinical trials. The aim of study was to assess the effectivenes ...
